(Q35128735)

6 August 2017

title

Survival rates with uveal melanoma in the United States: 1973-1997. (English)

1 reference

6 August 2017

main subject

United States of America

0 references

1 reference

Arun D Singh

1

1 reference

6 August 2017

Allan Topham

series ordinal

2

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

110

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

962-965

1 reference

Prognostic factors in uveal melanoma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Radiation therapy for choroidal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Transpupillary thermotherapy: results in 50 patients with choroidal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Melanogenic neuroectodermal tumor of the retina (primary malignant melanoma of the retina)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Incidence of uveal melanoma in the United States: 1973-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Cause-specific versus all-cause survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Melanomas of eye: stability of rates

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

Uveal melanoma: implications of tumor doubling time

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900077-0

7 January 2021

10.1016/S0161-6420(03)00077-0

Identifiers

DOI

1 reference

6 August 2017

1 reference